Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 8, 2017

Primary Completion Date

December 15, 2022

Study Completion Date

December 31, 2026

Conditions
Heart Defect, Congenital
Interventions
DEVICE

Xeltis Bioabsorbable Pulmonary Valved Conduit

Surgical implantation of Xeltis Bioabsorbable Pulmonary Valved Conduit

Trial Locations (10)

10032

New York Presbyterian Hospital - Columbia University (Xplore1), New York

15224

Children's Hospital of Pittsburgh of UPMC (Xplore1), Pittsburgh

33021

Joe DiMaggio Children's Hospital, Hollywood

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

80045

Children's Hospital Colorado, Aurora

90027

Children's Hospital of Los Angeles, Los Angeles

75390-8835

UTSW- Dallas Children's Hospital, Dallas

Unknown

"Multiprofile Hospital for Active Treatment National cardiology hospital EAD, Department of Congenital Heart Defects Surgery", Sofia

Institut Jantung Negara Sdn Bhd, Kuala Lumpur

University Children's Hospital of Cracow, Krakow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Xeltis

INDUSTRY